NASDAQ Newsroom NASDAQ Investor Relations Listed Companies How our Market Works NASDAQ Corporate www.NASDAQ.com
Nasdaq
Web NASDAQ.com   

John C. Martin, PhD, President and Chief Executive Officer of Gilead Sciences, presides over the Market Open
 

John C. Martin, PhD, President and Chief Executive Officer of Gilead Sciences, Rings The NASDAQ Stock Market Opening Bell

John C. Martin, PhD, President and Chief Executive Officer of Gilead Sciences,
Rings The NASDAQ Stock Market Opening Bell

Friday, December 1, 2006
at NASDAQ's MarketSite
in New York City.


Gilead Sciences

 
Additional Photographs & Reprint Permissions
Archived MarketSite Events | Summary Quote

John C. Martin, PhD, President and Chief Executive Officer of Gilead Sciences, presides over the Opening bell.
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia. For more information on Gilead Sciences, please visit the company's website at www.gilead.com.

Reprints

Click for larger pictures of the NASDAQ MarketSite.

Additional Photographs for 12/1/2006

© Copyright 2006, The NASDAQ Stock Market, Inc.
Reprinted with the permission of The Nasdaq Stock Market, Inc.